HEMLIBRA ® (emicizumab-kxwh) injection

HEMLIBRA ® (emicizumab-kxwh) injection

HEMLIBRA is a bispecific factor IXa- and factor X-directed antibody indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients ages newborn and older with hemophilia A